Magnesium isoglycyrrhizinate blocks fructose‐induced hepatic NF‐&kgr;B/NLRP3 inflammasome activation and lipid metabolism disorder
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2017.05.032
Abstract: &NA; Magnesium isoglycyrrhizinate as a hepatoprotective agent possesses immune modulation and anti‐inflammation, and treats liver diseases. But its effects on immunological‐inflammatory and metabolic profiles for metabolic syndrome with liver injury and underlying potential mechanisms are… read more here.
Keywords: isoglycyrrhizinate; magnesium isoglycyrrhizinate; activation; nlrp3 inflammasome ... See more keywords